ALDX
ALDX
NASDAQ · Biotechnology

Aldeyra Therapeutics Inc

$2.19
+0.38 (+20.99%)
As of Mar 23, 3:46 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 11 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +1,871.7% upside
Low Target $31.72
Average Target $43.18
High Target $59.84
Current Price $2.19
Current
$2.19
Target
$43.18
$31.72 $43.18 avg $59.84
Scenario Analysis
Bear Case
$31.72
1,348.4%
Low target
Base Case
$43.18
+1,871.7%
Avg target
Bull Case
$59.84
+2,632.4%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$7.20
-69.6% from high
52-Week Low
$1.14
+92.1% from low
Target vs 52W High
$43.18
+499.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%